Metabolomics as a tool towards personalized medicine in type 2 diabetes mellitus
نویسندگان
چکیده
منابع مشابه
Metabolomics: moving towards personalized medicine
In many fields of medicine there is a growing interest in characterizing diseases at molecular level with a view to developing an individually tailored therapeutic approach. Metabolomics is a novel area that promises to contribute significantly to the characterization of various disease phenotypes and to the identification of personal metabolic features that can predict response to therapies. B...
متن کاملpath to personalized medicine for type 2 diabetes mellitus: reality and hope
type 2 diabetes mellitus (t2dm) is recognized as a public health problem and increasingly prevalent illness. key elements of the guideline for diabetes care are based on evidence-based medicine approach and apply for population, not individuals. however, individualized care can improve diabetes management. personalized medicine is otherwise called precision medicine tries to find better predict...
متن کاملPersonalized medicine in Type 2 Diabetes
Type 2 diabetes (T2D) is a global public health concern, its prevalence in Asia, especially Taiwan, rising every year. The risk of developing T2D and diabetes complications is not only controlled by environmental but also by genetic factors. Genetic association studies have shown polymorphisms at specific loci may help identify individuals at greatest risk and response to oral antidiabetic drug...
متن کاملCommentary Metabolomics : moving towards personalized medicine
In many fields of medicine there is a growing interest in characterizing diseases at molecular level with a view to developing an individually tailored therapeutic approach. Metabolomics is a novel area that promises to contribute significantly to the characterization of various disease phenotypes and to the identification of personal metabolic features that can predict response to therapies. B...
متن کاملSulfonylurea: Personalized Medicine for Type 2 Diabetes
Recently, new drugs targeting different glucose-regulating mechanisms have been brought to market and the pharmacological treatment of type 2 diabetes has become complex and more controversial. Clinicians can be confused about how to manage their patients optimally. Consequently, the American Diabetes Association and European Association for the Study of Diabetes published a consensus algorithm...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Revista de Medicina de Laboratorio
سال: 2021
ISSN: 2660-7638,2660-7484
DOI: 10.20960/revmedlab.00053